JAK inhibitors and VTE risk: how concerned should we be?
Crossref DOI link: https://doi.org/10.1038/s41584-021-00575-5
Published Online: 2021-01-15
Published Print: 2021-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cohen, Stanley B.
Text and Data Mining valid from 2021-01-15
Version of Record valid from 2021-01-15
Article History
First Online: 15 January 2021
Competing interests
: S.B.C. declares they have been a consultant and investigator for Abbvie, Eli Lilly, Gilead and Pfizer.